Addressing Dyslipidemia in Patients With Alagille Syndrome
We explore 2 case studies of pediatric patients diagnosed with Alagille syndrome who presented with dyslipidemia and discuss what we can learn from them.
We explore 2 case studies of pediatric patients diagnosed with Alagille syndrome who presented with dyslipidemia and discuss what we can learn from them.
Notch signaling is vital for healthy liver growth; when it becomes aberrant, various pathologies can occur, including Alagille syndrome.
We explore the complexities surrounding clinical studies on pregnant women with Alagille syndrome and how the disease may drive pathology in pregnancy.
We highlight why providing care in a multidisciplinary setting to patients with Alagille syndrome is indispensable.
Recent developments suggest that most diseases that have a genetic cause will be identified as such in the near future.
Although liver pathology is the most common feature of Alagille syndrome, patients may also have skeletal, facial, and cerebral abnormalities.
We discuss the sharp rise of telemedicine services in the US and what it means for cystic fibrosis patient care.
We explore the role of YAP1 in liver development and pathology, and question whether there is more than meets the eye in YAP1 research.
We discuss a report of a rare case of a patient with a background of Alagille syndrome developing hepatocellular carcinoma.
We explore the importance of assessing the nutritional status of infants diagnosed with a chronic cholestatic liver disease.